• Home
  • Contact
  • Newsletter
RSS

Print

 MailMail
  • Patients
  • Journalists
  • Partners
  • Investors
  • Products
  • Research
  • About Movetis
  • Jobs
Home

Site map

Left menu

  • Patients
    • Chronic constipation
  • Journalists
    • Press releases
    • Press about Movetis
    • Events
      • Scientific events
    • Press contact
  • Partners
    • Business opportunities
    • Partnering contact
  • Investors
    • English
      • News
      • Investor information
      • Share information
      • Analyst coverage
      • Shareholder structure
      • Corporate governance
      • Investor relations contact
    • Nederlands
      • Nieuws
      • Info voor investeerders
      • Aandelenkoers
      • Analisteninformatie
      • Aandeelhoudersstructuur
      • Corporate governance
      • Investor relations contact
  • Products
    • Resolor® (prucalopride)
    • Availability of Resolor® (prucalopride)
  • Research
    • Prucalopride
    • M0002
    • M0003
    • M0004
    • Pre-clinical compounds
    • Discovery projects
  • About Movetis
    • Who we are
      • The team
        • Movetis
        • Management team
        • Board of directors
        • Our people
    • Vision and mission
    • Business model
    • Milestones
    • Social responsibility
    • Corporate video
  • Jobs
    • Job openings
    • Submit your resume
RSS

Print

 MailMail
News Room
Browse through our press releases and find out what's new at Movetis.
Join the Mailinglist

to receive regular email updates

email address

 

Movetis NV, Veedijk 58 (1004), 2300 Turnhout, Belgium | contact | phone + 32 14 404 390

  • Sitemap
  • Privacy Policy
  • Terms of Use